T44 Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system

Codes

• T44.0Poisoning by, adverse effect of and underdosing of anticholinesterase agents

  • T44.0XPoisoning by, adverse effect of and underdosing of anticholinesterase agents

    • T44.0X1Poisoning by anticholinesterase agents, accidental (unintentional)

      • T44.0X1A..., initial encounter
      • T44.0X1D..., subsequent encounter
      • T44.0X1S..., sequela
    • T44.0X2Poisoning by anticholinesterase agents, intentional self-harm

      • T44.0X2A..., initial encounter
      • T44.0X2D..., subsequent encounter
      • T44.0X2S..., sequela
    • T44.0X3Poisoning by anticholinesterase agents, assault

      • T44.0X3A..., initial encounter
      • T44.0X3D..., subsequent encounter
      • T44.0X3S..., sequela
    • T44.0X4Poisoning by anticholinesterase agents, undetermined

      • T44.0X4A..., initial encounter
      • T44.0X4D..., subsequent encounter
      • T44.0X4S..., sequela
    • T44.0X5Adverse effect of anticholinesterase agents

      • T44.0X5A..., initial encounter
      • T44.0X5D..., subsequent encounter
      • T44.0X5S..., sequela
    • T44.0X6Underdosing of anticholinesterase agents

      • T44.0X6A..., initial encounter
      • T44.0X6D..., subsequent encounter
      • T44.0X6S..., sequela
• T44.1Poisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics]

  • T44.1XPoisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics]

    • T44.1X1Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional)

      • T44.1X1A..., initial encounter
      • T44.1X1D..., subsequent encounter
      • T44.1X1S..., sequela
    • T44.1X2Poisoning by other parasympathomimetics [cholinergics], intentional self-harm

      • T44.1X2A..., initial encounter
      • T44.1X2D..., subsequent encounter
      • T44.1X2S..., sequela
    • T44.1X3Poisoning by other parasympathomimetics [cholinergics], assault

      • T44.1X3A..., initial encounter
      • T44.1X3D..., subsequent encounter
      • T44.1X3S..., sequela
    • T44.1X4Poisoning by other parasympathomimetics [cholinergics], undetermined

      • T44.1X4A..., initial encounter
      • T44.1X4D..., subsequent encounter
      • T44.1X4S..., sequela
    • T44.1X5Adverse effect of other parasympathomimetics [cholinergics]

      • T44.1X5A..., initial encounter
      • T44.1X5D..., subsequent encounter
      • T44.1X5S..., sequela
    • T44.1X6Underdosing of other parasympathomimetics [cholinergics]

      • T44.1X6A..., initial encounter
      • T44.1X6D..., subsequent encounter
      • T44.1X6S..., sequela
• T44.2Poisoning by, adverse effect of and underdosing of ganglionic blocking drugs

  • T44.2XPoisoning by, adverse effect of and underdosing of ganglionic blocking drugs

    • T44.2X1Poisoning by ganglionic blocking drugs, accidental (unintentional)

      • T44.2X1A..., initial encounter
      • T44.2X1D..., subsequent encounter
      • T44.2X1S..., sequela
    • T44.2X2Poisoning by ganglionic blocking drugs, intentional self-harm

      • T44.2X2A..., initial encounter
      • T44.2X2D..., subsequent encounter
      • T44.2X2S..., sequela
    • T44.2X3Poisoning by ganglionic blocking drugs, assault

      • T44.2X3A..., initial encounter
      • T44.2X3D..., subsequent encounter
      • T44.2X3S..., sequela
    • T44.2X4Poisoning by ganglionic blocking drugs, undetermined

      • T44.2X4A..., initial encounter
      • T44.2X4D..., subsequent encounter
      • T44.2X4S..., sequela
    • T44.2X5Adverse effect of ganglionic blocking drugs

      • T44.2X5A..., initial encounter
      • T44.2X5D..., subsequent encounter
      • T44.2X5S..., sequela
    • T44.2X6Underdosing of ganglionic blocking drugs

      • T44.2X6A..., initial encounter
      • T44.2X6D..., subsequent encounter
      • T44.2X6S..., sequela
• T44.3Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

  • T44.3XPoisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

    • T44.3X1Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional)

      • T44.3X1A..., initial encounter
      • T44.3X1D..., subsequent encounter
      • T44.3X1S..., sequela
    • T44.3X2Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm

      • T44.3X2A..., initial encounter
      • T44.3X2D..., subsequent encounter
      • T44.3X2S..., sequela
    • T44.3X3Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault

      • T44.3X3A..., initial encounter
      • T44.3X3D..., subsequent encounter
      • T44.3X3S..., sequela
    • T44.3X4Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined

      • T44.3X4A..., initial encounter
      • T44.3X4D..., subsequent encounter
      • T44.3X4S..., sequela
    • T44.3X5Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

      • T44.3X5A..., initial encounter
      • T44.3X5D..., subsequent encounter
      • T44.3X5S..., sequela
    • T44.3X6Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

      • T44.3X6A..., initial encounter
      • T44.3X6D..., subsequent encounter
      • T44.3X6S..., sequela
• T44.4Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

  • T44.4XPoisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

    • T44.4X1Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)

      • T44.4X1A..., initial encounter
      • T44.4X1D..., subsequent encounter
      • T44.4X1S..., sequela
    • T44.4X2Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm

      • T44.4X2A..., initial encounter
      • T44.4X2D..., subsequent encounter
      • T44.4X2S..., sequela
    • T44.4X3Poisoning by predominantly alpha-adrenoreceptor agonists, assault

      • T44.4X3A..., initial encounter
      • T44.4X3D..., subsequent encounter
      • T44.4X3S..., sequela
    • T44.4X4Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined

      • T44.4X4A..., initial encounter
      • T44.4X4D..., subsequent encounter
      • T44.4X4S..., sequela
    • T44.4X5Adverse effect of predominantly alpha-adrenoreceptor agonists

      • T44.4X5A..., initial encounter
      • T44.4X5D..., subsequent encounter
      • T44.4X5S..., sequela
    • T44.4X6Underdosing of predominantly alpha-adrenoreceptor agonists

      • T44.4X6A..., initial encounter
      • T44.4X6D..., subsequent encounter
      • T44.4X6S..., sequela
• T44.5Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

  • T44.5XPoisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

    • T44.5X1Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)

      • T44.5X1A..., initial encounter
      • T44.5X1D..., subsequent encounter
      • T44.5X1S..., sequela
    • T44.5X2Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm

      • T44.5X2A..., initial encounter
      • T44.5X2D..., subsequent encounter
      • T44.5X2S..., sequela
    • T44.5X3Poisoning by predominantly beta-adrenoreceptor agonists, assault

      • T44.5X3A..., initial encounter
      • T44.5X3D..., subsequent encounter
      • T44.5X3S..., sequela
    • T44.5X4Poisoning by predominantly beta-adrenoreceptor agonists, undetermined

      • T44.5X4A..., initial encounter
      • T44.5X4D..., subsequent encounter
      • T44.5X4S..., sequela
    • T44.5X5Adverse effect of predominantly beta-adrenoreceptor agonists

      • T44.5X5A..., initial encounter
      • T44.5X5D..., subsequent encounter
      • T44.5X5S..., sequela
    • T44.5X6Underdosing of predominantly beta-adrenoreceptor agonists

      • T44.5X6A..., initial encounter
      • T44.5X6D..., subsequent encounter
      • T44.5X6S..., sequela
• T44.6Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists

  • T44.6XPoisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists

    • T44.6X1Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional)

      • T44.6X1A..., initial encounter
      • T44.6X1D..., subsequent encounter
      • T44.6X1S..., sequela
    • T44.6X2Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm

      • T44.6X2A..., initial encounter
      • T44.6X2D..., subsequent encounter
      • T44.6X2S..., sequela
    • T44.6X3Poisoning by alpha-adrenoreceptor antagonists, assault

      • T44.6X3A..., initial encounter
      • T44.6X3D..., subsequent encounter
      • T44.6X3S..., sequela
    • T44.6X4Poisoning by alpha-adrenoreceptor antagonists, undetermined

      • T44.6X4A..., initial encounter
      • T44.6X4D..., subsequent encounter
      • T44.6X4S..., sequela
    • T44.6X5Adverse effect of alpha-adrenoreceptor antagonists

      • T44.6X5A..., initial encounter
      • T44.6X5D..., subsequent encounter
      • T44.6X5S..., sequela
    • T44.6X6Underdosing of alpha-adrenoreceptor antagonists

      • T44.6X6A..., initial encounter
      • T44.6X6D..., subsequent encounter
      • T44.6X6S..., sequela
• T44.7Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists

  • T44.7XPoisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists

    • T44.7X1Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional)

      • T44.7X1A..., initial encounter
      • T44.7X1D..., subsequent encounter
      • T44.7X1S..., sequela
    • T44.7X2Poisoning by beta-adrenoreceptor antagonists, intentional self-harm

      • T44.7X2A..., initial encounter
      • T44.7X2D..., subsequent encounter
      • T44.7X2S..., sequela
    • T44.7X3Poisoning by beta-adrenoreceptor antagonists, assault

      • T44.7X3A..., initial encounter
      • T44.7X3D..., subsequent encounter
      • T44.7X3S..., sequela
    • T44.7X4Poisoning by beta-adrenoreceptor antagonists, undetermined

      • T44.7X4A..., initial encounter
      • T44.7X4D..., subsequent encounter
      • T44.7X4S..., sequela
    • T44.7X5Adverse effect of beta-adrenoreceptor antagonists

      • T44.7X5A..., initial encounter
      • T44.7X5D..., subsequent encounter
      • T44.7X5S..., sequela
    • T44.7X6Underdosing of beta-adrenoreceptor antagonists

      • T44.7X6A..., initial encounter
      • T44.7X6D..., subsequent encounter
      • T44.7X6S..., sequela
• T44.8Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic-neuron- blocking agents

  • T44.8XPoisoning by, adverse effect of and underdosing of centrally-acting and adrenergic- neuron-blocking agents

    • T44.8X1Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional)

      • T44.8X1A..., initial encounter
      • T44.8X1D..., subsequent encounter
      • T44.8X1S..., sequela
    • T44.8X2Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm

      • T44.8X2A..., initial encounter
      • T44.8X2D..., subsequent encounter
      • T44.8X2S..., sequela
    • T44.8X3Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault

      • T44.8X3A..., initial encounter
      • T44.8X3D..., subsequent encounter
      • T44.8X3S..., sequela
    • T44.8X4Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined

      • T44.8X4A..., initial encounter
      • T44.8X4D..., subsequent encounter
      • T44.8X4S..., sequela
    • T44.8X5Adverse effect of centrally-acting and adrenergic-neuron-blocking agents

      • T44.8X5A..., initial encounter
      • T44.8X5D..., subsequent encounter
      • T44.8X5S..., sequela
    • T44.8X6Underdosing of centrally-acting and adrenergic-neuron-blocking agents

      • T44.8X6A..., initial encounter
      • T44.8X6D..., subsequent encounter
      • T44.8X6S..., sequela
• T44.9Poisoning by, adverse effect of and underdosing of other and unspecified drugs primarily affecting the autonomic nervous system

  • T44.90Poisoning by, adverse effect of and underdosing of unspecified drugs primarily affecting the autonomic nervous system

    • T44.901Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional)

      • T44.901A..., initial encounter
      • T44.901D..., subsequent encounter
      • T44.901S..., sequela
    • T44.902Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm

      • T44.902A..., initial encounter
      • T44.902D..., subsequent encounter
      • T44.902S..., sequela
    • T44.903Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault

      • T44.903A..., initial encounter
      • T44.903D..., subsequent encounter
      • T44.903S..., sequela
    • T44.904Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined

      • T44.904A..., initial encounter
      • T44.904D..., subsequent encounter
      • T44.904S..., sequela
    • T44.905Adverse effect of unspecified drugs primarily affecting the autonomic nervous system

      • T44.905A..., initial encounter
      • T44.905D..., subsequent encounter
      • T44.905S..., sequela
    • T44.906Underdosing of unspecified drugs primarily affecting the autonomic nervous system

      • T44.906A..., initial encounter
      • T44.906D..., subsequent encounter
      • T44.906S..., sequela
  • T44.99Poisoning by, adverse effect of and underdosing of other drugs primarily affecting the autonomic nervous system

    • T44.991Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional)

      • T44.991A..., initial encounter
      • T44.991D..., subsequent encounter
      • T44.991S..., sequela
    • T44.992Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm

      • T44.992A..., initial encounter
      • T44.992D..., subsequent encounter
      • T44.992S..., sequela
    • T44.993Poisoning by other drug primarily affecting the autonomic nervous system, assault

      • T44.993A..., initial encounter
      • T44.993D..., subsequent encounter
      • T44.993S..., sequela
    • T44.994Poisoning by other drug primarily affecting the autonomic nervous system, undetermined

      • T44.994A..., initial encounter
      • T44.994D..., subsequent encounter
      • T44.994S..., sequela
    • T44.995Adverse effect of other drug primarily affecting the autonomic nervous system

      • T44.995A..., initial encounter
      • T44.995D..., subsequent encounter
      • T44.995S..., sequela
    • T44.996Underdosing of other drug primarily affecting the autonomic nervous system

      • T44.996A..., initial encounter
      • T44.996D..., subsequent encounter
      • T44.996S..., sequela